Brent Zanke
Fondatore presso ArcticDX, Inc.
Profilo
Brent Zanke is the founder of ArcticDX, Inc. where he holds the title of Director starting in 2006.
Dr. Zanke is also the founder of CTRL Therapeutics, Inc. Dr. Zanke's former job was as Director at Cross Cancer Institute.
Dr. Zanke earned a doctorate degree from the University of Toronto in 1993 and another doctorate degree from the University of Manitoba in 1983.
Posizioni attive di Brent Zanke
| Società | Posizione | Inizio |
|---|---|---|
ArcticDX, Inc.
 ArcticDX, Inc. Medical/Nursing ServicesHealth Services ArcticDX, Inc. designs molecular diagnostic testing services. It provides age-related macular degeneration progression and AMD pharmacogenetics which is used to optimize therapeutic outcomes, determine the appropriate dose for a patient, and avoid harmful effects. The company was founded by Brent Zanke and Gregory C. Hines in 2005 and is headquartered in Toronto, Canada. | Fondatore | 10/06/2010 |
Precedenti posizioni note di Brent Zanke
| Società | Posizione | Fine |
|---|---|---|
CTRL Therapeutics, Inc.
 CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Amministratore Delegato | - |
| Cross Cancer Institute | Direttore/Membro del Consiglio | - |
Formazione di Brent Zanke
| University of Toronto | Doctorate Degree |
| University of Manitoba | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
ArcticDX, Inc.
ArcticDX, Inc. Medical/Nursing ServicesHealth Services ArcticDX, Inc. designs molecular diagnostic testing services. It provides age-related macular degeneration progression and AMD pharmacogenetics which is used to optimize therapeutic outcomes, determine the appropriate dose for a patient, and avoid harmful effects. The company was founded by Brent Zanke and Gregory C. Hines in 2005 and is headquartered in Toronto, Canada. | Health Services |
| Cross Cancer Institute | |
CTRL Therapeutics, Inc.
CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- Brent Zanke